TAM
AMRX icon

Tocqueville Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Tocqueville Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-18,837
Closed -$418K – 749
2018
Q3 		$418K Hold
18,837
– – 0.01% 648
2018
Q2 		$309K Buy
+18,837
New +$331K ﹤0.01% 691

Other funds holding AMRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Tocqueville Asset Management's AMRX Position: Q4 2018 in Review

Tocqueville Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2018, closing a stake of 18,837 shares — an estimated $418K sold.

Tocqueville Asset Management first reported a position in AMRX in Q2 2018 and held it in 2 quarters. The position peaked at $418K in Q3 2018. 168 funds tracked by Wall St. Rank hold AMRX as of Q4 2018.

  • Tocqueville Asset Management reported no remaining Amneal Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Tocqueville Asset Management sold 18,837 Amneal Pharmaceuticals shares in Q4 2018, an estimated $418K.
  • Tocqueville Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Tocqueville Asset Management's Amneal Pharmaceuticals position peaked at $418K in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2018.

Based on Tocqueville Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.